KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Assets Average (2016 - 2026)

Pacific Biosciences Of California has reported Assets Average over the past 15 years, most recently at $793.6 million for Q4 2025.

  • For Q4 2025, Assets Average fell 41.44% year-over-year to $793.6 million; the TTM value through Dec 2025 reached $793.6 million, down 41.44%, while the annual FY2025 figure was $1.0 billion, 32.0% down from the prior year.
  • Assets Average for Q4 2025 was $793.6 million at Pacific Biosciences Of California, down from $814.3 million in the prior quarter.
  • Over five years, Assets Average peaked at $2.0 billion in Q1 2022 and troughed at $793.6 million in Q4 2025.
  • A 5-year average of $1.5 billion and a median of $1.6 billion in 2024 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: skyrocketed 457.23% in 2021 and later tumbled 46.96% in 2025.
  • Year by year, Assets Average stood at $1.2 billion in 2021, then skyrocketed by 43.52% to $1.8 billion in 2022, then grew by 1.63% to $1.8 billion in 2023, then fell by 25.62% to $1.4 billion in 2024, then plummeted by 41.44% to $793.6 million in 2025.
  • Business Quant data shows Assets Average for PACB at $793.6 million in Q4 2025, $814.3 million in Q3 2025, and $843.1 million in Q2 2025.